Finance

Lists
HYL:EBR
Hyloris Pharmaceuticals SA
4,25 €
-0,70%
(-0,030) 1D
19 қаз., 14:25:06 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HYL...
Open
4,11 €
High
4,25 €
Low
4,02 €
Mkt. cap
119,00 млн
Avg. vol.
5,76 мың
Volume
1,87 мың
52-wk high
8,40 €
52-wk low
3,38 €
EPS
-0,17 €
Shares outstanding
28,00 млн
No. of employees
54
Open
4,11 €
High
4,25 €
Low
4,02 €
Mkt. cap
119,00 млн
Avg. vol.
5,76 мың
Volume
1,87 мың
52-wk high
8,40 €
52-wk low
3,38 €
EPS
-0,17 €
Shares outstanding
28,00 млн
No. of employees
54
News stories
From web sources and news partners
About Hyloris Pharmaceuticals SA
CEOStijn Van Rompay
Employees54
Founded2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
2,30 млн
2,30 млн
2,61 млн
2,61 млн
Cost of goods sold
125,50 м.
125,50 м.
149,00 м.
149,00 м.
Cost of revenue
125,50 м.
125,50 м.
149,00 м.
149,00 м.
Research and development expenses
3,15 млн
3,15 млн
2,08 млн
2,08 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,34 млн
1,34 млн
1,26 млн
1,26 млн
Operating expense
4,49 млн
4,49 млн
3,17 млн
3,17 млн
Total operating expenses
4,61 млн
4,61 млн
3,32 млн
3,32 млн
Operating income
-2,31 млн
-2,31 млн
-707,00 м.
-707,00 м.
Other non operating income
87,00 мың
87,00 мың
-3,00 мың
-3,00 мың
EBT including unusual items
-1,50 млн
-1,50 млн
-937,50 м.
-937,50 м.
EBT excluding unusual items
-2,20 млн
-2,20 млн
-700,50 м.
-700,50 м.
Income tax expense
-106,00 м.
-106,00 м.
-
-
Effective tax rate
7,09%
7,09%
-
-
Other operating expenses
-6,50 мың
-6,50 мың
-173,50 м.
-173,50 м.
Net income
-1,39 млн
-1,39 млн
-937,50 м.
-937,50 м.
Net profit margin
-60,41%
-60,41%
-35,87%
-35,87%
Earnings per share
-
-
-
-
Interest and investment income
271,00 м.
271,00 м.
42,00 мың
42,00 мың
Interest expense
-14,00 мың
-14,00 мың
-21,50 мың
-21,50 мың
Net interest expenses
257,00 м.
257,00 м.
20,50 мың
20,50 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,00 млн
-2,00 млн
-518,50 м.
-518,50 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары